Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Harrington

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Ultrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RTKevin J Harrington
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Oncolytic virotherapy needs trials, not access programsKevin J Harrington
The Lancet. Oncology|February 5, 2010
Rash conclusions from a phase 3 study of cetuximab?Kevin J Harrington
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
From novel insights in molecular biology to targeted treatment approaches in head and neck cancerKevin J Harrington
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
Reply to N.F. Saba and S.J. WongKevin J Harrington, Jean Bourhis
JAMA Oncology|November 22, 2023
Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck-ReplyKevin J Harrington, Robert Haddad
Oral and Maxillofacial Surgery Clinics of North America|April 11, 2022
Management of Head and Neck Mucosal MelanomaPablo Nenclares, Kevin J Harrington
The Lancet. Oncology|May 4, 2010
Bravo for PRAVOKevin J Harrington, Christopher M Nutting
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Human Papillomavirus-Negative Pharyngeal CancerMagnus T Dillon, Kevin J Harrington
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?Kevin J Harrington, Christopher M Nutting
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Ultrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RTKevin J Harrington
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Oncolytic virotherapy needs trials, not access programsKevin J Harrington
The Lancet. Oncology|February 5, 2010
Rash conclusions from a phase 3 study of cetuximab?Kevin J Harrington
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
From novel insights in molecular biology to targeted treatment approaches in head and neck cancerKevin J Harrington
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
Reply to N.F. Saba and S.J. WongKevin J Harrington, Jean Bourhis
JAMA Oncology|November 22, 2023
Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck-ReplyKevin J Harrington, Robert Haddad
Oral and Maxillofacial Surgery Clinics of North America|April 11, 2022
Management of Head and Neck Mucosal MelanomaPablo Nenclares, Kevin J Harrington
The Lancet. Oncology|May 4, 2010
Bravo for PRAVOKevin J Harrington, Christopher M Nutting
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Human Papillomavirus-Negative Pharyngeal CancerMagnus T Dillon, Kevin J Harrington
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?Kevin J Harrington, Christopher M Nutting
Pageof 32